Novavax Rises After Rovi of Spain to Buy Flu Vaccine Technology (Bloomberg)
June 30 (Bloomberg) -- Novavax Inc. surged as much as 40 percent after announcing Rovi Pharmaceuticals will use its technology to help vaccinate the population of Spain against the flu.
Article Submitted by Marbella Guide
Disclaimer: The owners of this site make no claim to the quality of the content submitted and are not responsible for any breach in copyright as these articles are fed in directly from the publishers web site
Please contact the publisher of this page here if you have any copyright issues or questions.
